XMTR Jumps As Wedbush Sets Aggressive $126 Price Target

Xometry Inc. stocks have been trading up by 4.24 percent, driven primarily by strong demand outlook in manufacturing services

Weekly Update Jul 13 – Jul 17, 2026: On Friday, July 17, 2026 Xometry Inc. stock [NASDAQ: XMTR] is trending up by 4.24%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Industrials industry expert:

Analyst sentiment – positive

Xometry occupies a differentiated position as a scaled, AI‑enabled manufacturing marketplace with strong topline momentum but unfinished work on profitability. Revenue of ~$687m and 3/5‑year CAGRs of 22.5%/36.1% validate demand, and a 39% gross margin shows solid take‑rate economics. However, EBIT margin remains negative at -6.2%, ROE at -18.7%, and ROIC firmly subscale. Cash metrics are improving: Q1 operating cash flow of $14.6m and positive free cash flow underscore increasing capital discipline.

Technically, XMTR is in a constructive intermediate uptrend, consolidating just below psychological resistance at $100 after a series of higher weekly highs and closes clustered in the mid‑ to high‑90s. The 5‑minute tape shows orderly intraday pullbacks being bought with rising volume into strength, suggesting institutional accumulation rather than speculative spikes. The actionable level is $100–101: a weekly close above this band is a clean breakout trigger, with risk managed against short‑term support around $95.

Near‑term catalysts skew favorable. Wedbush’s Outperform initiation and $126 target validate the AI‑enabled marketplace thesis versus Industrials/Capital Goods peers still early on digitalization. Product upgrades in injection molding, stronger certified‑supplier economics, and visible aerospace/defense and energy demand all support durable share gains. Insider CFO selling is modest versus holdings and not thesis‑changing. I view fair 12‑month upside to $120, with support at $90 and resistance now at $100; risk‑reward remains attractive for growth‑oriented investors.

Quick Financial Overview

Xometry Inc. sits at an interesting crossroads for traders. The stock is trading just under $100, with recent weekly closes between about $95 and $99, while Wedbush is calling for $126. That gap is what creates attention — and potential opportunity — for active XMTR traders. The company’s trailing revenue is about $686.6M, with three-year growth above 20% and five-year growth above 36%, confirming it as a fast-growing marketplace despite current losses.

Margins are still negative, which is key for risk management. Xometry Inc. runs gross margin near 39.3%, but EBIT margin is about -6.2% and profit margin around -7%. Returns on equity and assets are clearly negative, reflecting the cost of scaling an AI-driven platform. Balance sheet-wise, a current ratio around 1.8 and quick ratio about 1.7 show decent short-term liquidity, while total debt-to-equity near 1.2 and long-term debt of roughly $252M mean leverage is meaningful but not extreme.

Cash flow tells a different story from GAAP earnings. In the latest quarter ending 2026/03/31, Xometry Inc. posted net income of about -$5.3M but generated operating cash flow of roughly $14.6M and free cash flow around $14.6M as well. That swing is driven largely by non-cash items like stock-based compensation and working-capital moves, backed by revenue of about $205.1M and gross profit of roughly $78.5M in the quarter. For traders, that mix of negative earnings, improving cash flow, and strong top-line growth sets up a classic high-beta growth profile.

Conclusion

XMTR is trading like a growth platform name where sentiment can shift quickly on news and price levels. Recent intraday action shows a strong push from the low $90s at the open to over $101 midday, then a fade back toward $98–$99 into the close. That is classic expansion-and-digestion behavior after a catalyst, and the Wedbush Outperform call with a $126 target gives bulls a clear reference point. Multiple intraday rotations around the $99–$101 area mark an important near-term battleground for short-term traders.

Fundamentally, Xometry Inc. is still losing money but growing fast, with solid gross margins and improving free cash flow. The enhanced injection molding tools and AI-driven quoting, plus the strong demand from aerospace, defense, energy, and industrial buyers, support the Wedbush view that this is a scaled, high-value marketplace rather than a simple job board. The Xometry Foundation adds soft brand strength, while the CFO share sale is a data point to note, not a thesis breaker, given his remaining stake.

For active traders, the risk/reward hinges on whether XMTR can hold the mid-to-high $90s and build a base toward triple digits while news flow stays constructive. Clear upside sentiment is anchored by the $126 target, but negative margins and leverage mean pullbacks can be sharp. As I tell my students, “Your edge in names like XMTR comes from respecting both the story and the levels — let the price action confirm the narrative before you size up.” As millionaire penny stock trader and teacher Tim Sykes, says, “Small gains add up over time; focus on building wealth gradually, not chasing jackpots.”, and that mindset applies directly to navigating volatile names like XMTR, where disciplined trade management and incremental profits often beat swinging for home runs. This article is for educational and research purposes only.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks